Virios Therapeutics Llc (VIRI) Stock
VIRI is no longer traded. Virios Therapeutics Llc was delisted from the Nasdaq in December 2024.
Prices on this page are historical; the last trade was December 10, 2024 at $2.74.
Virios Therapeutics Llc stock price history
VIRI final trading statistics
- Final close
- $2.74
- Final trading day
- Dec 10, 2024
- Market cap at delisting
- $206.5K
- Shares outstanding
- 1.33M
- Final 52-week range
- $0.13 – $5.29
- Avg. volume (final 3 mo.)
- 107,203
- All-time high (split-adj.)
- $417.75 · Dec 2020
- All-time low (split-adj.)
- $1.85 · Nov 2024
- Return since IPO
- -99.3%
- Beta
- 1.58
- Book value / share
- $2.82
- Price / book
- 0.97
Virios Therapeutics Llc annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $0.00 | -$5.3M | -$0.28 |
| FY2022 | $0.00 | -$12.2M | -$1.31 |
| FY2021 | $0.00 | -$16.0M | -$1.91 |
| FY2020 | $0.00 | -$10.3M | -$1.80 |
| FY2019 | $0.00 | -$2.8M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Virios Therapeutics Llc
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, Inc. in July 2020. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.
Virios Therapeutics Llc stock FAQ
What happened to Virios Therapeutics Llc stock?
Virios Therapeutics Llc stock was delisted from the Nasdaq. Its final close was $2.74 on December 10, 2024.
Is VIRI stock still trading?
No. VIRI was delisted from the Nasdaq in December 2024 and no longer trades on a U.S. exchange.
What was the last price of VIRI stock?
VIRI closed at $2.74 on its final trading day, December 10, 2024, for a market value of about $206.5K.
What were Virios Therapeutics Llc's revenue and earnings in its last full fiscal year?
Virios Therapeutics Llc reported revenue of $0.00 and net income of -$5.3M in fiscal 2023, its last full year as a public company.
When did Virios Therapeutics Llc go public?
Virios Therapeutics Llc stock began trading on December 17, 2020.